Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration
Advanced Healthcare Materials · 2025-09 · 14 (25)
DOI: 10.1002/adhm.202502341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.07.2025. Verfasst von Hongjuan Weng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Complex Tissue Regeneration Department, MERLN Institute for Technology Inspired Regenerative Medicine, Maastricht University, Maastricht, 6229 ER, Th…. Hauptthemen laut MEDLINE: Hydrogels, Collagen, Bioprinting, Regeneration. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Dutch Research Council (NWO) Gravitation Program, ERC-PoC project.
Abstract (Originalsprache)
Collagen peptide (COP) is water soluble, bioactive, and tends to be a promising alternative to collagen for tissue regeneration. However, its low viscosity and lack of readily polymerizable groups hinder its bioprinting and limit its wide applications in tissue engineering. In this study, methacrylated collagen peptide‐xanthan gum (COPMA‐XG) bioinks with interpenetrating networks are developed for bioprinting stable constructs, followed by stem cell differentiation. First, self‐healing COPMA hydrogels are developed with rapid UV‐curing and tunable mechanical properties. To increase the printability and the mechanical properties of COPMA, XG is mixed to create a set of COPMA‐XG bioinks. COPMA‐XG hydrogels show self‐healing properties, optimal printability, and stable morphology in the medium. The bioprinted human bone marrow mesenchymal stem cells (hMSCs) laden COPMA‐XG constructs are biocompatible and bioactive, with increased production of extracellular matrix, collagen type I, and scleraxis over 28 days. Overall, bioprinted COPMA‐XG constructs are versatile matrices to support hMSCs proliferation and differentiation with potential for ligament tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Complex Tissue Regeneration Department, MERLN Institute for Technology Inspired Regenerative Medicine, Maastricht University, Maastricht, 6229 ER, The Netherlands.
- Sustainable Polymer Synthesis group, Aachen-Maastricht Institute for Biobased Materials, Maastricht University, Geleen, 6167 RD, The Netherlands.
- Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Groningen, 9713 AV, The Netherlands.
- Instructive Biomaterials Engineering Department, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, 6229 ER, The Netherlands.
ORCID-Profile: Lorenzo Moroni
Förderung
- China Scholarship Council
- Dutch Research Council (NWO) Gravitation Program
- ERC-PoC project
- InterLynk Innovation Program
Zitieren
APA
Weng, H., Decarli, M. C., He, L., Chen, W., van Rijt, S., Bernaerts, K. V., & Moroni, L. (2025). Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration. Advanced Healthcare Materials, 14(25). https://doi.org/10.1002/adhm.202502341
Vancouver
Weng H, Decarli MC, He L, Chen W, van Rijt S, Bernaerts KV, et al. Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration. Advanced Healthcare Materials. 2025;14(25). doi:10.1002/adhm.202502341
BibTeX
@article{Weng2025,
author = {Weng, Hongjuan and Decarli, Monize Caiado and He, Lei and Chen, Wen and van Rijt, Sabine and Bernaerts, Katrien V and Moroni, Lorenzo},
title = {Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {25},
doi = {10.1002/adhm.202502341}
}
EUVIMED